Cargando…

Accuracy of endoscopic staging and targeted biopsies for routine gastric intestinal metaplasia and gastric atrophy evaluation study protocol of a prospective, cohort study: the estimate study

INTRODUCTION: Patients with chronic atrophic gastritis (CAG) and intestinal metaplasia (IM) are at risk of developing gastric adenocarcinoma. Their diagnosis and management currently rely on histopathological guidance after random endoscopic biopsy sampling (Sydney biopsy strategy). This approach ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nieuwenburg, Stella A V, Waddingham, William W, Graham, David, Rodriguez-Justo, Manuel, Biermann, Katharina, Kuipers, Ernst J, Banks, Matthew, Jansen, Marnix, Spaander, Manon C W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Gastroenterology and Hepatology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6756576/ https://www.ncbi.nlm.nih.gov/pubmed/31537576 http://dx.doi.org/10.1136/bmjopen-2019-032013

Ejemplares similares

Recent advances in the detection and management of early gastric cancer and its precursors
por: Waddingham, William, et al.
Publicado: (2020)

NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case–control study
por: Masclee, Gwen M C, et al.
Publicado: (2015)

A digital pathology workflow for the segmentation and classification of gastric glands: Study of gastric atrophy and intestinal metaplasia cases
por: Barmpoutis, Panagiotis, et al.
Publicado: (2022)

Development of plasma ghrelin level as a novel marker for gastric mucosal atrophy after Helicobacter pylori eradication
por: Yang, Hang, et al.
Publicado: (2022)

Development of plasma ghrelin level as a novel marker for gastric mucosal atrophy after Helicobacter pylori eradication
por: Mori, Hideki, et al.
Publicado: (2022)

Response to letter regarding: development of plasma ghrelin level as a novel marker for gastric mucosal atrophy after Helicobacter pylori eradication
por: Mori, Hideki, et al.
Publicado: (2022)

Phenotype characteristics of gastric epithelial mucus in patients with different gastric diseases: from superficial gastritis to gastric cancer
por: Dong, Nannan, et al.
Publicado: (2021)

Changes in gastric mucosal microbiota in gastric carcinogenesis: a systematic review protocol
por: Ji, Ruoyu, et al.
Publicado: (2021)

Longitudinal outcome monitoring in patients with chronic gastroduodenal symptoms investigated using the Gastric Alimetry system: study protocol
por: Varghese, Chris, et al.
Publicado: (2023)

Prediction models for the survival in patients with intestinal-type gastric adenocarcinoma: a retrospective cohort study based on the SEER database
por: Hong, Jiawen, et al.
Publicado: (2023)

Gastric emergencies in older adults: not always the same old story! A tertiary care emergency department observational cohort study
por: Rosa, Fausto, et al.
Publicado: (2022)

Characteristic analysis of early gastric cancer after Helicobacter pylori eradication: a multicenter retrospective propensity score-matched study
por: Liu, Xinyuan, et al.
Publicado: (2023)

Awareness of risk factors and warning symptoms and attitude towards gastric cancer screening among the general public in China: a cross-sectional study
por: Liu, Qi, et al.
Publicado: (2019)

Diagnostic accuracy of linked colour imaging versus white light imaging for early gastric cancers: a prospective, multicentre, randomized controlled trial study
por: Min, Min, et al.
Publicado: (2022)

Hybrid Argon Plasma Coagulation for Treatment of Gastric Intestinal Metaplasia
por: Estifan, Elias, et al.
Publicado: (2020)

Predicting Gastric Intestinal Metaplasia in a High-Risk Population
por: Akpoigbe, Kesiena, et al.
Publicado: (2022)

Clinicopathologic features and prognosis of 71 patients with gastric cancer and disseminated intravascular coagulation
por: Chen, Ling, et al.
Publicado: (2023)

Sorting nexin-1 is a candidate tumor suppressor and potential prognostic marker in gastric cancer
por: Zhan, Xiao-Yong, et al.
Publicado: (2018)

The diagnostic value of serum insulin-like growth factor binding protein 7 in gastric cancer
por: Liu, Can-Tong, et al.
Publicado: (2023)

Heterogeneity in outcome assessment for inflammatory bowel disease in routine clinical practice: a mixed-methods study in a sample of English hospitals
por: Razanskaite, Violeta, et al.
Publicado: (2021)

Anlotinib combined with SOX regimen (S1 (tegafur, gimeracil and oteracil porassium capsules) + oxaliplatin) in treating stage IV gastric cancer: study protocol for a single-armed and single-centred clinical trial
por: Wang, Juan, et al.
Publicado: (2020)

Discovery of plasma messenger RNA as novel biomarker for gastric cancer identified through bioinformatics analysis and clinical validation
por: Cao, Wei, et al.
Publicado: (2019)

Analysis of factors contributing to postoperative body weight change in patients with gastric cancer: based on generalized estimation equation
por: Tian, Qiuju, et al.
Publicado: (2020)

Endoscopic submucosal dissection versus endoscopic mucosal resection for patients with early gastric cancer: a meta-analysis
por: Tao, Maogen, et al.
Publicado: (2019)

Impact of Helicobacter pylori on the gastric microbiome in patients with chronic gastritis: a systematic review and meta-analysis protocol
por: Cao, Xinyuan, et al.
Publicado: (2023)

Undifferentiated-predominant mixed-type early gastric cancer is more aggressive than pure undifferentiated type: a systematic review and meta-analysis
por: Yang, Peng, et al.
Publicado: (2022)

Fistulizing Gastric GIST
por: Costa, Mariana, et al.
Publicado: (2015)

Efficacy of quadruple regimen with polaprezinc for gastric Helicobacter pylori infection eradication: protocol for a single-centre, single-blind, non-inferiority, randomised clinical trial
por: Wu, Dingkun, et al.
Publicado: (2020)

Long-term outcomes and clinical safety of expanded indication early gastric cancer treated with endoscopic submucosal dissection versus surgical resection: a meta-analysis
por: Xu, Xing, et al.
Publicado: (2022)

Is administration of proton pump inhibitors in functional dyspepsia worth the risk of developing gastric cancer: a Markov model to bridge the gap between scientific evidence and clinical practice
por: Broide, Efrat, et al.
Publicado: (2020)

Factors associated with the progression of gastric intestinal metaplasia: a multicenter, prospective cohort study
por: Nieuwenburg, S. A. V., et al.
Publicado: (2021)

Gastric Mixed Adenoneuroendocrine Carcinoma
por: Fernandes, Dália, et al.
Publicado: (2015)

Comparative efficacy and safety of anti-HGF/MET pathway agents plus chemotherapy versus chemotherapy alone as first-line treatment in advanced gastric cancer: a protocol for a systematic review and meta-analysis
por: Jiang, Zhiyuan, et al.
Publicado: (2021)

Study protocol for a multicentre nationwide prospective cohort study to investigate the natural course and clinical outcome in benign liver tumours and cysts in the Netherlands: the BELIVER study
por: Furumaya, Alicia, et al.
Publicado: (2022)

Can routine blood tests be modelled to detect advanced liver disease in the community: model derivation and validation using UK primary and secondary care data
por: Hydes, Theresa, et al.
Publicado: (2021)

Protocol of a prospective, monocentric phase I/II feasibility study investigating the safety of multimodality treatment with a combination of intraoperative chemotherapy and surgical resection in locally confined or borderline resectable pancreatic cancer: the combiCaRe study
por: Roth, Susanne, et al.
Publicado: (2019)

An Unusual Endoscopic Finding of Gastric Crohn's Disease
por: Garrido, Isabel, et al.
Publicado: (2021)

Helicobacter pylori infection in patients with inflammatory bowel diseases: a single-centre, prospective, observational study in Egypt
por: Abd El-Wahab, Ekram W., et al.
Publicado: (2022)

Lengthening adalimumab dosing interval in quiescent Crohn’s disease patients: protocol for the pragmatic randomised non-inferiority LADI study
por: Smits, L J T, et al.
Publicado: (2020)

Australia IBD Microbiome (AIM) Study: protocol for a multicentre longitudinal prospective cohort study
por: Williams, Astrid-Jane, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1cpa6kv8m0bqea9u7iopn5t0g4